tion is the specific removal of the methyl groups by an Japan enzymatically driven reaction. We have previously proposed that arginine deimination, a process involved in the biosynthetic processing 
2002).
To test for histone deiminase activity, the PADI4 citrulline (cit, Figure 2B ). The sequencing could not determine whether R26 in the tail was modified. We thereprotein was expressed recombinantly as a GST fusion and added to a purified preparation of all four histones.
fore used a peptide that overlaps this residue as a substrate for PADI4. Mass spectrometry indicates that R26 To monitor the conversion of arginines to citrulline, an antibody was used that detects a chemically modified can also be converted to citrulline by PADI4 ( Figure 4B and Supplemental Data available at http://www.cell. version of citrulline (Senshu et al., 1992) . Figure 1C shows that this anticitrulline antibody detects histone com/cgi/content/full/118/5/545/DC1). To monitor more specifically the deimination of H3 H3 specifically, only when recombinant PADI4 and calcium are added to histones (lane 3). The histone H3 in vivo we raised an antibody that recognizes deiminated H3. The Cit-H3 antibody ( Figure 3 ) was raised against detected is a faster migrating variant of H3, presumably due to the reduction of the positive charge as a result a peptide corresponding to the tail of H3 with citrulline present in the place of R2, R8, and R17 ( Figure 3A ). of arginine deimination. To ensure that the enzymatic activity of PADI4 was responsible for the modifications Figure 3B shows that the Cit-H3 antibody recognizes the faster migrating deiminated H3, which is generated of H3 observed in Figure 1C lane 3, a mutant of PADI4 was expressed in which a conserved region of C-terwhen PADI4 is incubated with H3. No reactivity is observed with unmodified H3 ( Figure 3B ) or with other minal residues was deleted. This PADI4 mutant was unable to generate the faster migrating deiminated hishistones treated by PADI4 ( Figure 3C ). Use of this antibody in Western blots indicates that H3 has virtually tone H3 band ( Figure 1D ). These results suggest that PADI4 is able to specifically deiminate histone H3 when undetectable levels of citrulline in cultured MCF-7 cells ( Figure 3D , lane 1). However, when PADI4 is overexpresented with all four core histones as potential substrates.
pressed in these cells, detection of deiminated H3 by the Cit-H3 antibody increases substantially ( Figure 3D , To map the sites of deimination we used a tailless form of H3, which lacks the first 26 N-terminal residues. lane 2). These results confirm that endogenous H3 tail arginine residues are deiminated by the action of PADI4. This region of H3 contains the N-terminal arginine residues that are targeted for methylation by CARM1 Schurter et al., 2001 ). Figure 2A shows that Deimination Antagonizes Arginine Methylation These results demonstrate that PADI4 has the capacity PADI4 can deiminate full-length but not the tailless version of H3. Identification of the sites of deimination in to deiminate all four arginines in the tail of histone H3. Three of these (R2, R17, R26) are known substrates the H3 tail was carried out by N-terminal sequencing, which showed that R2, R8, and R17 are converted to for the CARM1 methyltransferase. We next tested the awaits the availability of reagents to generate monocific zinc finger DNA binding domain (ZFa). The PADI4 deiminase was delivered in parallel fused to a second methylated H3 peptides or monomethyl arginine histone H3 specific antibodies.
VEGF-A targeting zinc finger DNA binding domain (ZFb), directing this domain to two sites in close proximity to the first (ZFa) on the VEGF-A promoter ( Figure 5A ) to PADI4 Represses Hormone-Receptor Regulated Transcription monitor its effect on hormone-dependent activation. As a control for the specificity of the effects of PADI4 on Given the ability of PADI4 to block arginine methylation within H3, we next sought to establish if PADI4 can hormone-dependent activation, the PADI4 zinc finger protein fusion was used to challenge the transcriptional regulate transcription via its enzymatic activity. To characterize the functions of PADI4 in regulating transcripactivation of VEGF-A by a p65 (RelA) zinc finger fusion, which stimulates VEGF-A transcription in a hormonetion, we utilized a system that has been used for the analysis of other chromatin-modifying enzymes. Directly independent manner. Figure 5B shows that the activation of VEGF-A by the targeting the lysine methyltransferases Suv39H1 and G9a to an endogenous promoter via an engineered zinc ER-ZFa in the presence of E2 hormone is repressed by the PADI4-ZFb. In contrast, PADI4-ZFb is unable to finger DNA binding domain has shown that these enzymes can specifically induce transcriptional repression repress the constitutive activity of the p65-ZF fusion. PADI4-ZFb is also unable to repress transcriptional actiof endogenous chromatinized genes in vivo via their enzymatic activities (Snowden et al., 2002) . This system vation mediated by a VP16-ZFa fusion (data not shown). Figure 5C shows that PADI4-ZFb can also repress the was used to ask whether PADI4 is a repressor and if repression is specific to the nuclear hormone-signaling thyroid hormone dependent activation of the VEGF-A promoter. Significantly, repression of TR-ZFa mediated pathway, which is known to be regulated by arginine methylation (Figure 5 Figure 6E ) Taken together the analysis of the pS2 promoter indicates that deimination (1) is implicated in estrogenmediated signaling, like arginine methylation and (2) appears on the promoter when the gene is disengaged from RNA polymerase II and arginine dimethylation of H3 is at a minimum. These results suggest that deimination and arginine methylation have opposing effects on gene expression.
Discussion
Here, we report the identification of PADI4 as a histone H3 specific arginine deiminase with a potential to re- In one pathway, PADI4 has the potential to block any lation has been shown to occur in cycles following estrogen stimulation so mechanisms must exist to demethyltransferase from signaling to arginines, since conversion to citrulline eliminates the possibility of methylate arginines. Various novel pathways may be operational including the existence of a demethylase methylation taking place. This block of methylation (I, Figure 7 ) may occur in either a spatial or a temporal activity, or the replacement of a dimethylated histone with an unmodified variant. The possibility also exists, sense. A spatial block (deimination of specific nucleosomes) may limit the function of arginine methylation to however, that PADI4 itself may be able to deiminate dimethylated arginine when modified or part of a specific localized regions within a gene. A temporal block may allow the ordered appearance of arginine methylation complex in vivo. Alternatively, another PADI family member may have the potential to carry out this conversion. on a given gene during a hormone response. The block to methylation by deimination could also occur on a Figure 6 clearly demonstrates that the appearance of citrulline on the pS2 promoter is transient. This suggests gene-to-gene basis, rather than within a gene. The action of PADI4 on certain genes may occlude them from that mechanisms exist that will rapidly remove citrulline after it appears in the H3 tail. The removal of citrulline being responsive to activation by arginine methylation.
In a second pathway, PADI4 may reverse a methylamay be mediated by aminotransferase enzymes that can convert citrulline back into arginine. Biosynthetic tion event that has already taken place (II, Figure 7) . Our results raise the possibility that monomethyl arginine enzymes that can catalyze this type of reaction are known to exist (Bannister et al., 2002 ). There may be (and not dimethyl arginine) is a substrate for PADI4 deimination. Thus, PADI4 may act as an enzyme, which in homologs of these that are active on peptidyl substrates and could function on citrulline in histones. Alternatively, essence, can act as a demethylase for a specific methylarginine state.
a histone variant replacement pathway may be operational which exchanges the deiminated histone with one The functional significance of monoarginine methylation is not known, but this is the methyl state found containing arginines. This would mean that the block or reversal of arginine methylation by deimination can itself exclusively when bulk histones are analyzed by mass spectrometry (Strahl et were performed using SybrGreen (Applied Biosystems) as a marker derivatives of amino acids were identified using an "on-line" HPLC for DNA amplification on an ABI Prism 7000 apparatus (Applied system (AB) equipped with a PTH C18 (2.1 ϫ 220 mm; 5 micron Biosystems). The 5Ј to 3Ј sequences of the primers used to detect particle size) column ( 
